Introduction: Despite some improvement in provision of safe drinking water, proper sanitation and hygiene promotion, cholera still remains a major public health problem in Malawi with outbreaks occurring almost every year since 1998. In response to 2014/2015 cholera outbreak, ministry of health and partners made a decision to assess the feasibility and acceptability of conducting a mass oral cholera vaccine (OCV) as an additional public health measure. This paper highlights the burden of the 2014/15 cholera outbreak, successes and challenges of OCV campaign conducted in March and April 2015.

Methods: This was a documentation of the first OCV campaign conducted in Malawi. The campaign targeted over 160,000 people aged one year or more living in 19 camps of people internally displaced by floods and their surrounding communities in Nsanje district. It was a reactive campaign as additional measure to improved water, sanitation and hygiene in response to the laboratory confirmed cholera outbreak.

Results: During the first round of the OCV campaign conducted from 30 March to 4 April 2015, a total of 156,592 (97.6%) people out of 160,482 target population received OCV. During the second round (20 to 25 April 2015), a total of 137,629 (85.8%) people received OCV. Of these, 108,247 (67.6%) people received their second dose while 29,382 (18.3%) were their first dose. Of the 134,836 people with known gender and sex who received 1 or 2 doses, 54.4% were females and over half (55.4%) were children under the age of 15 years. Among 108,237 people who received 2 doses (fully immunized), 54.4% were females and 51.9% were children under 15 years of age. No severe adverse event following immunization was reported. The main reason for non-vaccination or failure to take the 2 doses was absence during the period of the campaign.

Conclusion: This documentation has demonstrated that it was feasible, acceptable by the community to conduct a large-scale mass OCV campaign in Malawi within five weeks. Of 320,000 OCV doses received, Malawi managed to administer at least 294,221 (91.9%) of the doses. OCV could therefore be considered to be introduced as additional measure in cholera hot spot areas in Malawi.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4907756PMC
http://dx.doi.org/10.11604/pamj.2016.23.203.8346DOI Listing

Publication Analysis

Top Keywords

ocv campaign
16
campaign conducted
12
people received
12
ocv
9
feasibility acceptability
8
oral cholera
8
cholera vaccine
8
sanitation hygiene
8
public health
8
cholera outbreak
8

Similar Publications

Descriptive analysis of adverse events following immunization with oral cholera vaccine in Lebanon.

Front Public Health

December 2024

Quality Assurance of Pharmaceutical Products Department, National Pharmacovigilance Program, Lebanese Ministry of Public Health, Beirut, Lebanon.

Background: A national Oral Cholera Vaccine (OCV) Euvichol-Plus® campaign was launched in Lebanon, in response to the first outbreak in three decades, recorded in October 2022. The OCV vaccination campaign was carried out between November 2022 and February 2023. This study aims to cover adverse events reports, received at the Lebanese National Pharmacovigilance Program's (LNPVP) passive surveillance system.

View Article and Find Full Text PDF
Article Synopsis
  • Oral cholera vaccination (OCV) campaigns are being evaluated for their cost-effectiveness in refugee camps, particularly in the Maela camp in Thailand, where cholera outbreaks occur with a notable incidence rate.
  • The analysis showed that the economic costs of the OCV campaign were significant, totaling around USD 289,561, with a high incremental cost per death averted, but it indicated that higher cholera incidence or case fatality rates could improve cost-effectiveness.
  • Sensitivity analyses demonstrated that adjusting the case fatality rate or incidence could lead to more favorable cost-per-DALY (disability-adjusted life years) figures, suggesting strategic use of OCV campaigns in outbreak-prone areas.
View Article and Find Full Text PDF

Background: In 2019-2020, preventative Oral Cholera Vaccine campaigns were conducted in 24/32 non-contiguous health areas of Goma, DR Congo. In August 2022, we measured coverage and factors potentially influencing success of the delivery strategy.

Methods: We used random geo-sampled stratified cluster survey to estimate OCV coverage and assess population movement, diarrhea history, and reasons for non-vaccination.

View Article and Find Full Text PDF
Article Synopsis
  • - Diarrheal diseases, particularly cholera, pose a significant risk to Rohingya refugees in Cox's Bazar due to overcrowding and poor hygiene, leading to the establishment of a cholera surveillance network in 2017 to monitor and respond to outbreaks.
  • - Over six years, the network collected 17,252 stool samples, with a 3.5% positivity rate for cholera, showing an increase in culture-confirmed cases from 2021 to 2023 compared to earlier years.
  • - Key risk factors for cholera included young children aged 2-4 years and inadequate water treatment practices, emphasizing the need for hygiene improvements and the use of oral cholera vaccines in outbreak prevention strategies. *
View Article and Find Full Text PDF

Background: Cholera outbreaks in Ethiopia necessitate frequent mass oral cholera vaccine (OCV) campaigns. Despite this, there is a notable absence of a comprehensive summary of these campaigns. Understanding national OCV vaccination history is essential to design appropriate and effective cholera control strategies.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!